Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:abiraterone_acetate
|
| gptkbp:approvalYear |
2018
|
| gptkbp:ATCCode |
L02BX03
|
| gptkbp:chemicalFormula |
C26H33NO2
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
micronized tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Yonsa
|
| gptkbp:indication |
prostate cancer
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sun_Pharma
|
| gptkbp:mechanismOfAction |
CYP17 inhibitor
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
edema hypertension urinary tract infection hypokalemia hot flush |
| gptkbp:usedFor |
gptkb:methylprednisolone
|
| gptkbp:bfsParent |
gptkb:Sun_Pharma
gptkb:North_Hamgyong |
| gptkbp:bfsLayer |
6
|